Variant-specific monoclonal and group-specific polyclonal human immunodeficiency virus type 1 neutralizing antibodies raised with synthetic peptides from the gp120 third variable domain.

The third variable (V3) domain of the human immunodeficiency virus type 1 (HIV-1) external membrane glycoprotein gp120 is of crucial importance in eliciting neutralizing antibodies in infected persons. Polyclonal (PAb) and monoclonal (MAb) antibodies directed against selected epitopes in the V3 doma...

詳細記述

保存先:

書誌詳細
出版年:	J Virol
主要な著者:	Laman, J D, Schellekens, M M, Abacioglu, Y H, Lewis, G K, Tersmette, M, Fouchier, R A, Langedijk, J P, Claassen, E, Boersma, W J
フォーマット:	Artigo
言語:	Inglês
出版事項:	American Society for Microbiology (ASM) 1992
主題:	Research Article
オンライン･アクセス:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC240953/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1637373/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.66.3.1823-1831.1992
タグ:	タグ追加タグなし, このレコードへの初めてのタグを付けませんか!

Variant-specific monoclonal and group-specific polyclonal human immunodeficiency virus type 1 neutralizing antibodies raised with synthetic peptides from the gp120 third variable domain.

類似資料